Listed by the USPTO as LEE, ANDREW P
Tech Center 1600 • Art Units: 1621 1628 1629 1691
This examiner grants 48% of resolved cases
LEE, ANDREW P works in Tech Center 1600 and Art Unit 1621. The record includes 594 resolved cases, an allowance rate of 48.5%, and a median of 1215 days to allowance. Interviews are associated with a 22.8% lift in allowance outcomes. The data indicates that applicants should anticipate meaningful prosecution work and may benefit from purposeful examiner engagement.
The listed companies are Auspex Pharmaceuticals LLC, Gilead Sciences Inc., and The Regents of the University of Michigan. The listed firms are BakerHostetler, Clark+Elbing LLP, and Arnall Golden Gregory LLP. Counsel can use interviews to explore claim direction while planning for the longer pendency reflected in the record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18279232 | Small Molecule Degraders of CBP/p300 Proteins | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18466041 | IMPROVED ANIMAL FEED COMPOSITIONS AND METHODS OF USE | Final Rejection | Syngenta Participations AG |
| 17771737 | THERAPEUTIC APPROACH FOR TREATING INFLAMMATORY BOWEL DISEASE | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18336712 | THE MODE OF ACTION OF N-MeDCPA ON TRPC CHANNELS | Non-Final OA | The United States Government as represented by the Department of Veterans Affairs |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy48.5% of resolved applications examined by Andrew P Lee were allowed (594 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.
This examiner's interview lift is +22.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Andrew P Lee took 1,215 days on average from filing to allowance.
Andrew P Lee examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
